DOVER, N.H.--(BUSINESS WIRE)--TissueLink Medical Inc., a privately held medical device company, announced today that earlier this year it completed its Series E financing totaling $20 million. Current investors Arnerich Massena & Associates and RiverVest Venture Partners led the financing round.
